Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicinesDesignation granted for warm autoimmune ...

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...

Tagum has yet to consistently contain the mosquito-borne dengue since November 27, 2023, when the city declared a state of ...

Discover the impact of cold water on your body from improved circulation to boosted energy and enhanced immune function.

Childhood leukemia symptoms can be subtle. Learn how to recognize early warning signs and when to seek medical advice.

The measles outbreak in West Texas has worsened, with a 20% rise in cases over three days, surpassing 400. Unvaccinated ...

See whether you need to delay vaccinations if your child has a minor sickness, such as a low-grade fever, ear infection, or ...

Company to Feature First and Only Ready-to-Use Liquid Vigabatrin at Booth #846 MAPLE GROVE, Minn., April 4, 2025 /PRNewswire/ -- Upsher-Smi ...

While some forms of hair loss are irreversible, others can be improved. In our essential guide, we've teamed up with experts ...

Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune hemolytic an ...

Renee is urging anyone who is eligible to donate blood or platelets to do so. She said it only takes a bit of time and can save other kids and teens, like Jocey.

“Your blood count is dangerously low,” the doctor said over the phone. “I’m sending an ambulance to take you to the hospital ...